stars 1 stars 2 stars 3

SoLongevity promotes healthy ageing. How? By developing treatments and products, validated through solid clinical studies that aim to preserve what the World Health Organization has defined “physiological reserve”, that is the individual “capital-longevity” with which we are born and which constitutes the potential for health and wellbeing for the years to come. Our solutions are intended to allow each person to reach and maintain their maximum potential, preventing the risk conditions related to aging diseases. “Pathological” ageing is a phenomenon that is not only multifactorial but also articulated in a different and specific way for each individual. For this reason, Solongevity adopts the methods of Precision Medicine to the science of aging, to ensure the best individual effectiveness in preventing and combating the degenerative processes related to it. SoLongevity is also a platform for clinical translation of research centres’ outcomes, methods and technologies in the field of Healthy-Aging, open to cooperate with international scientific excellences that share the same vision.

SoLongevity Questions

Claudio Migliavacca is the Digital and Communication Director of SoLongevity.

10 people are employed at SoLongevity.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users